Lantheus Holdings, Inc. (0L8.F)

Compare

84.26

-1.42

(-1.66%)

At close: April 4 at 5:52:32 PM GMT+2

3 Leading Stocks Estimated To Be Up To 45.9% Below Intrinsic Value

As the U.S. stock market faces heightened volatility amid escalating trade tensions and economic uncertainty, major indices like the Dow Jones and Nasdaq have entered correction and bear market territories, respectively. In such turbulent times, identifying stocks that are trading below their intrinsic value can be a strategic approach for investors seeking potential opportunities in undervalued assets.

Simply Wall St. yesterday

SLP

DSP

LNTH
Lantheus Completes Acquisition of Evergreen Theragnostics

BEDFORD, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced that it has completed its previously announced acquisition of Evergreen Theragnostics, Inc. (“Evergreen”), a clinical-stage radiopharmaceutical company. The acquisition was first announced on January 28, 2025. Th

GlobeNewswire 5 days ago

LNTH
Returns On Capital Are A Standout For Lantheus Holdings (NASDAQ:LNTH)

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Typically...

Simply Wall St. 11 days ago

LNTH
Is Lantheus Holdings, Inc. (LNTH) the Best Healthcare Stock For Long-Term Investment?

We recently published a list of 10 Best Healthcare Stocks For Long-Term Investment. In this article, we are going to take a look at where Lantheus Holdings, Inc. (NASDAQ:LNTH) stands against other best healthcare stocks for long-term investment. Rising Healthcare Costs and the Impact of Tariffs on the US Industry In the US, healthcare expenditures […]

Insider Monkey 22 days ago

LNTH
Q4 Earnings Highs And Lows: Lantheus (NASDAQ:LNTH) Vs The Rest Of The Medical Devices & Supplies - Imaging, Diagnostics Stocks

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - imaging, diagnostics industry, including Lantheus (NASDAQ:LNTH) and its peers.

StockStory 27 days ago

LNTH

HOLX

GE
Lantheus Holdings' (NASDAQ:LNTH) Soft Earnings Are Actually Better Than They Appear

Lantheus Holdings, Inc.'s ( NASDAQ:LNTH ) stock was strong despite it releasing a soft earnings report last week. Our...

Simply Wall St. last month

LNTH
Lantheus Holdings (NasdaqGM:LNTH) Sees 19% Surge Following 2024 Earnings US$1.534 Billion Sales Increase

Lantheus Holdings (NasdaqGM:LNTH) saw an 18.83% increase in its share price over the past week, driven by recent corporate updates and market trends. The company announced its 2024 earnings, reporting a sales increase to $1.534 billion, though net income fell to $312 million, and confirmed its 2025 revenue guidance, projecting growth up to $1.610 billion. Completing its share repurchase program further consolidated investor confidence. These corporate communications appeared to have bolstered...

Simply Wall St. last month

LNTH
LNTH: 2025 Guidance Provided

By John Vandermosten, CFA NASDAQ:LNTH READ THE FULL LNTH RESEARCH REPORT Lantheus Holdings, Inc. (NASDAQ:LNTH) reported 2024 financial and operational results on February 26 th , producing sales of over $1 billion for Pylarify during the calendar year. Other products also made a material contribution including Definity, which rose almost 14% in part due to opportunistic sales. The company

Zacks Small Cap Research last month

LNTH

CATX
3 Stocks That Might Be Priced Below Their Estimated Intrinsic Value

As the U.S. stock market experiences a slight rebound, with major indices like the S&P 500 and Nasdaq Composite snapping their recent losing streaks, investors are keenly observing economic indicators and corporate earnings for signs of stability. In this environment, identifying stocks that may be priced below their intrinsic value can offer potential opportunities for those looking to capitalize on market inefficiencies.

Simply Wall St. last month

BEKE

INTU

LNTH
Lantheus Holdings Inc (LNTH) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid ...

Lantheus Holdings Inc (LNTH) reports robust sales growth for PYLARIFY and DEFINITY, while navigating increased operating expenses and strategic investments.

GuruFocus.com last month

LNTH
Q4 2024 Lantheus Holdings Inc Earnings Call

Q4 2024 Lantheus Holdings Inc Earnings Call

Thomson Reuters StreetEvents last month

LNTH
Lantheus (LNTH) Shares Skyrocket, What You Need To Know

Shares of radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) jumped 19.8% in the morning session after the company delivered strong fourth-quarter 2024 results, with revenue and earnings topping analysts' expectations. Sales rose 10.5% year-on-year, fueled by high demand for its radiopharmaceutical products, including PYLARIFY, which crossed $1 billion in annual sales. For 2025, the company set a bullish earnings forecast, well above consensus estimates. However, its full-year revenue o

StockStory last month

LNTH
Lantheus’s (NASDAQ:LNTH) Q4 Sales Top Estimates, Stock Soars

Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 10.5% year on year to $391.1 million. On the other hand, the company’s full-year revenue guidance of $1.58 billion at the midpoint came in 2.3% below analysts’ estimates. Its non-GAAP profit of $1.59 per share was 3% above analysts’ consensus estimates.

StockStory last month

LNTH
Lantheus Holdings: Q4 Earnings Snapshot

The average estimate of seven analysts surveyed by Zacks Investment Research was for earnings of $1.58 per share. The diagnostic imaging company posted revenue of $391.1 million in the period, also exceeding Street forecasts. Seven analysts surveyed by Zacks expected $378.6 million.

Associated Press Finance last month

LNTH
Lantheus Reports Fourth Quarter and Full Year 2024 Financial Performance

Worldwide revenue of $391.1 million and $1.53 billion for the fourth quarter and full year 2024Free cash flow was $141.4 million and $493.1 million for the fourth quarter and full year 2024GAAP fully diluted loss per share of $(0.17) and earnings per share of $4.36 for the fourth quarter and full year 2024Adjusted fully diluted earnings per share of $1.59 and $6.76 for the fourth quarter and full year 2024PYLARIFY exceeds $1 billion in net sales and becomes first ever blockbuster radiodiagnostic

GlobeNewswire last month

LNTH
Earnings To Watch: Lantheus (LNTH) Reports Q4 Results Tomorrow

Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) will be reporting earnings tomorrow before market hours. Here’s what you need to know.

StockStory last month

LNTH
Investors in Lantheus Holdings (NASDAQ:LNTH) have seen incredible returns of 406% over the past five years

Lantheus Holdings, Inc. ( NASDAQ:LNTH ) shareholders have seen the share price descend 19% over the month. But that...

Simply Wall St. last month

LNTH
Lantheus to Present at Upcoming Investor Conferences

BEDFORD, Mass., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced members of its management team will present at the following upcoming investor conferences. B. Riley Securities Precision Oncology & Radiopharma Day in New York on February 28TD Cowen 45th Annual Health Care Conference in Boston o

GlobeNewswire last month

LNTH
Is Lantheus Holdings (LNTH) One of the Best Fast Growth Stocks to Buy Right Now?

We recently published a list of 15 Best Fast Growth Stocks To Buy Right Now. In this article, we are going to take a look at where Lantheus Holdings, Inc. (NASDAQ:LNTH) stands against other best fast growth stocks to buy right now. In the fourth quarter of 2024, the US Gross Domestic Product (GDP) expanded […]

Insider Monkey last month

LNTH
LNTH: Earnings Report Next Week

By John Vandermosten, CFA NASDAQ:LNTH READ THE FULL LNTH RESEARCH REPORT Lantheus Holdings, Inc. (NASDAQ:LNTH) began 2025 with a pair of potentially transformational acquisitions. As we look towards the earnings report next week, we update investors on the latest deals and review the company’s prospects. Lantheus is aggressively using the cash generated from its successful Pylarify PET imaging

Zacks Small Cap Research last month

LNTH

Performance Overview

Return	0L8.F	S&P 500 (^GSPC)
YTD	-3.61%	-13.73%
1-Year	+54.78%	-1.42%
3-Year	+60.50%	+10.72%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Lantheus Holdings, Inc. (0L8.F)

3 Leading Stocks Estimated To Be Up To 45.9% Below Intrinsic Value

Lantheus Completes Acquisition of Evergreen Theragnostics

Returns On Capital Are A Standout For Lantheus Holdings (NASDAQ:LNTH)

Is Lantheus Holdings, Inc. (LNTH) the Best Healthcare Stock For Long-Term Investment?

Q4 Earnings Highs And Lows: Lantheus (NASDAQ:LNTH) Vs The Rest Of The Medical Devices & Supplies - Imaging, Diagnostics Stocks

Lantheus Holdings' (NASDAQ:LNTH) Soft Earnings Are Actually Better Than They Appear

Lantheus Holdings (NasdaqGM:LNTH) Sees 19% Surge Following 2024 Earnings US$1.534 Billion Sales Increase

LNTH: 2025 Guidance Provided

3 Stocks That Might Be Priced Below Their Estimated Intrinsic Value

Lantheus Holdings Inc (LNTH) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid ...

Q4 2024 Lantheus Holdings Inc Earnings Call

Lantheus (LNTH) Shares Skyrocket, What You Need To Know

Lantheus’s (NASDAQ:LNTH) Q4 Sales Top Estimates, Stock Soars

Lantheus Holdings: Q4 Earnings Snapshot

Lantheus Reports Fourth Quarter and Full Year 2024 Financial Performance

Earnings To Watch: Lantheus (LNTH) Reports Q4 Results Tomorrow

Investors in Lantheus Holdings (NASDAQ:LNTH) have seen incredible returns of 406% over the past five years

Lantheus to Present at Upcoming Investor Conferences

Is Lantheus Holdings (LNTH) One of the Best Fast Growth Stocks to Buy Right Now?

LNTH: Earnings Report Next Week

Performance Overview